We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MEDI.OL

Price
253.00
Stock movement down
-8.00 (-3.07%)
Company name
Medistim ASA
Exchange
(OL
,
Currency
NOK
)
Sector
Healthcare >
Medical Devices
Market cap
4.62B
Ent value
4.68B
Price/Sales
7.29
Price/Book
12.05
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
35.25
Forward P/E
27.68
PEG
-
EPS growth
7.99%
1 year return
65.36%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

MEDI.OL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E35.25
Price to OCF16.68
Price to FCF20.11
Price to EBITDA30.60
EV to EBITDA30.96

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales7.29
Price to Book12.05
EV to Sales7.37

FINANCIALS

Per share

Loading...
Per share data
Current share count18.27M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)9.14

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash96.35M
Net receivables94.12M
Total current assets388.07M
Goodwill14.13M
Intangible assets62.45M
Property, plant and equipment0.00
Total assets535.04M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities123.75M
Total liabilities151.23M
Shareholder's equity383.81M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open262.00
Daily high262.00
Daily low253.00
Daily Volume20K
All-time high399.00
1y analyst estimate315.00
Beta1.19
EPS (TTM)-
Dividend per share0.00
Ex-div date9 May 2025
Next earnings date27 Feb 2026

Downside potential

Loading...
Downside potential data
MEDI.OLS&P500
Current price drop from All-time high-36.59%-1.08%
Highest price drop-66.92%-19.00%
Date of highest drop19 Nov 20248 Apr 2025
Avg drop from high-50.46%-2.64%
Avg time to new high-6 days
Max time to new high297 days89 days
COMPANY DETAILS
MEDI.OL (Medistim ASA) company logo
Marketcap
4.62B
Marketcap category
Mid-cap
Description
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Employees
154
Investor relations
-
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As the European market grapples with concerns over inflated AI stock valuations and shifting interest rate expectations, the pan-European STOXX Europe 600 Index recently saw a decline of 2.21%, reflec...
November 24, 2025
Medistim ASA (FRA:MD1) reports its best third quarter ever with significant growth in the Americas and Asia Pacific, despite challenges in the EMEA region.
October 26, 2025
Medistim (OB:MEDI) posted headline numbers that reinforce its growth trajectory, with revenue forecast to climb 7.5% per year, handily outpacing the wider Norwegian market’s expected 2.3% growth rate....
October 25, 2025
As European markets continue to rally, reaching record levels on the back of strong technology stocks and expectations for lower U.S. borrowing costs, investors are increasingly optimistic about small...
October 7, 2025
Medistim ASA (FRA:MD1) reports a robust 16.7% revenue growth in Q2 2025, driven by significant gains in the Americas and strategic product advancements.
August 21, 2025
In recent weeks, European markets have seen a positive uptick, with the pan-European STOXX Europe 600 Index rising by 1.18% amid easing trade tensions and optimism surrounding potential U.S. interest ...
August 20, 2025
The European market has recently seen mixed returns across major indices, with the pan-European STOXX Europe 600 Index remaining relatively flat and individual country indices showing varied performan...
July 9, 2025
As the European market experiences a positive shift, with the pan-European STOXX Europe 600 Index rising by 0.90% and major stock indexes across Germany, Italy, France, and the UK posting gains, inves...
June 10, 2025
Medistim ASA (FRA:MD1) reports a 35.7% revenue increase, driven by strong product sales and significant market expansion in Asia Pacific.
May 12, 2025
As the pan-European STOXX Europe 600 Index continues its upward trajectory, marking a fourth consecutive week of gains amid easing trade tensions between China and the U.S., small-cap stocks have been...
May 12, 2025
Next page